Alkaloids from Psychotria Target Sirtuins: In Silico and In Vitro Interaction Studies

• Published in: Planta medica Vol. 81; no. 6; pp. 517 - 524
• Main Authors: Sacconnay, Lionel, Ryckewaert, Lucie, dos Santos Passos, Carolina, Guerra, Maria Cristina, Kato, Lucilia, Alves de Oliveira, Cecilia Maria, Henriques, Amélia, Carrupt, Pierre-Alain, Simões-Pires, Claudia, Nurisso, Alessandra
• Format: Journal Article
• Language: English
• Published: Stuttgart · New York Georg Thieme Verlag KG 01.04.2015
• Subjects: Alkaloids - isolation & purification; Alkaloids - pharmacology; HEK293 Cells; Humans; Molecular Conformation; Molecular Dynamics Simulation; Original Papers; Psychotria - chemistry; Sirtuins - drug effects; inhibitors; docking; spp; sirtuins; alkaloids; Rubiaceae; molecular dynamics
• ISSN: 0032-0943; 1439-0221
• DOI: 10.1055/s-0034-1383261

Abstract Epigenetic enzymes such as histone deacetylases play a crucial role in the development of ageing-related diseases. Among the 18 histone deacetylase isoforms found in humans, class III histone deacetylases, also known as sirtuins, seem to be promising targets for treating neurodegenerative conditions. Recently, Psychotria alkaloids, mainly monoterpene indoles, have been reported for their inhibitory properties against central nervous system cholinesterase and monoamine oxidase proteins. Given the multifunctional profile of these alkaloids in the central nervous system, and the fact that the indole scaffold has been previously associated with sirtuin inhibition, we hypothesized that these indole derivatives could also interact with sirtuins. In the present study, alkaloids previously isolated from Psychotria spp. were evaluated for their potential interaction with human sirtuin 1 and sirtuin 2 by molecular docking and molecular dynamics simulation approaches. The in silico results allowed for the selection of five potentially active compounds, namely, prunifoleine, 14-oxoprunifoleine, E -vallesiachotamine, Z -vallesiachotamine, and vallesiachotamine lactone. The sirtuin inhibition of these compounds was confirmed in vitro in a dose-response manner, with preliminary information on their pharmacokinetics properties.